Delirium Clinical Trials

Find Delirium Clinical Trials Near You

Prediction of Postoperative Cognitive Dysfunction and Delirium: A Prospective Observational Study to Develop a Risk Score in Elderly Patients Undergoing Transurethral Resection

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Elderly patients undergoing transurethral resection are at increased risk of postoperative cognitive dysfunction (POCD) and delirium, which are associated with prolonged hospital stay, increased morbidity, and decreased quality of life. Identifying patients who are more likely to develop postoperative cognitive dysfunction or delirium remains a practical challenge in daily clinical practice. Better recognition of these patients may help tailor perioperative care and improve outcomes. This prospective observational study aims to identify perioperative factors associated with POCD and delirium in elderly patients undergoing transurethral resection and to develop a clinically applicable risk prediction model. Cognitive function and delirium are assessed using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM). Cognitive function and delirium will be evaluated using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM). The results of this study may support clinicians in recognizing vulnerable patients earlier and may contribute to more individualized perioperative management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Age ≥65 years

• Scheduled for transurethral resection procedure

• ASA physical status I-III

• Able to provide informed consent

• Adequate cognitive function to complete preoperative assessment

Locations
Other Locations
Turkey
Muğla Training and Research Hospital
RECRUITING
Muğla
Contact Information
Primary
Eylem Yasar, MD
eylemtarakci@gmail.com
+905332392622
Backup
Melike Korkmaz Toker, MD
meltoker@gmail.com
+905054747098
Time Frame
Start Date: 2026-04-05
Estimated Completion Date: 2026-11-15
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Muğla Sıtkı Koçman University

This content was sourced from clinicaltrials.gov